ArticleClinical pharmacology and therapeutics2026
Probabilistic Risk-Benefit Profile of Ticagrelor Monotherapy After Short Dual Antiplatelet Therapy: A Bayesian Analysis of the ULTIMATE-DAPT Trial.
Nan Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.